Name
HPB
Subjects
Malignant hepatobiliary disease
ISSN
1365-182X
Description
HPB is an international forum for clinical, scientific and educational communication. Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice. Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.
Impact Factor (2 years)
3.047
Publisher
Elsevier
Journal Webpage
Journal type
Hybrid Journal

Journals Publications
(All)



Results 1-1 of 1 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
12011PK11195, a peripheral benzodiazepine receptor ligand, potentiates cytotoxic action on cholangiocarcinoma cell linesPericleous, S. ; Mathieson, W. ; Middleton, Nicos ; McKay, S. ; Biswas, A. ; Thomas, G. ; Spalding, D. ; Hutchins, R.